Atlas Trials

Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma

Clinical trial NCT00883480 · COMPLETED

Trial details

NCT number
NCT00883480
Sponsor
Spanish Lung Cancer Group
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2005-06-01
Primary completion
2008-01-01
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.